Neratinib for extended adjuvant treatment of early stage HER2-positive breast cancer Neratinib is approved by the U.S. Food and Drug Administration for extended adjuvant treatment of early stage HER2-overexpressed/amplified breast cancer adult patients as adjuvant...
US FDA Approves Venetoclax for Previously Untreated Chronic Lymphocytic Leukemia Patients Venetoclax is a first-in-class, oral B-cell lymphoma-2 (BCL-2) inhibitor that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein and has been granted five...
Being diagnosed with any cancer always comes as a shock and induces fear not only in the patient, but the entire family of the affected patient. Leukemia is also one of those cancer that invokes much fear and traumatic emotions in the minds of the patient and their...
Introduction A lymphoma is a form of blood cancer. Lymphomas are cancerous cells of the lymphatic system in which these cells grow and spread in an uncontrolled way. A significant part of the immune system consists of the lymphatic system, which includes the bone...
Niraparib (Zejula): Getting to Know about Life-Knowing Treatment for Advanced Ovarian Cancer As the COVID-19 widens its fear, medical practitioners around the world are continuously working round the clock to find an effective solution for the deadly virus. Along with...
Recent Comments